4//SEC Filing
Borisy Alexis 4
Accession 0001610717-25-000270
CIK 0001628171other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:25 PM ET
Size
6.7 KB
Accession
0001610717-25-000270
Insider Transaction Report
Form 4
Borisy Alexis
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-26+11,574→ 11,574 totalExercise: $37.48Exp: 2035-06-26→ Common Stock (11,574 underlying) - Award
Common Stock
2025-06-26+3,142→ 2,338,884 total
Footnotes (2)
- [F1]Includes 3,142 Restricted Stock Units.
- [F2]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001319446
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:25 PM ET
- Size
- 6.7 KB